Recently I have included quite a few posts about Microsoft HealthVault, mentioning Peter Neupert from Microsoft and can be found under
the related reading section below. The foundation’s purpose is to support biomedical research by bringing together private industry to help NIH’s ability to fulfill its mandates through increased resources and contributions. You can visit the site and make a contribution as well.
More about the partnerships with the FNIH can be found here. With the foundation established, this opens more doors for contributions dedicated to science research that can eventually be brought to the clinical side of healthcare. I am glad we have someone included who can offer support with algorithms and software as well as bring some real value to the foundation as well. BD
FNIH is authorized to solicit and receive funds to support public-private partnerships.
“Research partnerships are biomedical research projects bringing the public sector and the private sector (corporations, private foundations, associations, academia, individual philanthropists, and the general public) together to solve a common goal and to accelerate medical research that might not otherwise be undertaken. In this role, the Foundation for NIH assists in providing scientific and technological resources required for solving persistent health challenges; helping support scientists to find novel approaches in disease prevention, diagnosis and treatment.”
BETHESDA, Md., Dec 11, 2008 -- The Foundation for the National Institutes of Health (FNIH) announced today the addition of five distinguished directors to its Board of Directors. These appointments were effective as of November 12, 2008. 
New board directors include: Dr. Joseph Feczko, Senior Vice President, Chief Medical Officer, Pfizer Inc.; Peter Neupert, Corporate Vice President, Health Solutions Group, Microsoft Corp.; Kurt L. Schmoke, Dean, Howard University School of Law; Dr. Samuel O. Thier, Professor Emeritus, Medicine and Health Care Policy at Harvard Medical School, Massachusetts General Hospital; and Anne Wojcicki, Co-Founder of 23andMe. Additional information on the newly appointed directors is available at www.fnih.org.
"We are very pleased to announce the election of these five new directors to the Foundation's Board," commented Dr. Charles Sanders, Chairman of the Board of the Foundation for NIH. "With each one comes extensive expertise, new perspectives and the expectation that they will further strengthen the Board as the foundation advances the important mission of the NIH."
About The Foundation for the NIH
The Foundation for the National Institutes of Health was established by the United States Congress to support the mission of the National Institutes of Health (NIH): improving health through scientific discovery. The foundation is transforming the way biomedical research is initiated, supported and conducted, and blazing the trail for a new era of discovery through innovative public-private collaborations. The foundation provides expertise, experience and an integrated infrastructure for creating new biomedical research and training initiatives across multiple disciplines in support of the mission and causes of NIH. It brings together industry, academia and the philanthropic community to collaborate, leverage resources and create unique opportunities to accelerate the pace of scientific discovery and biomedical research that may translate into successful healthcare solutions.
The Foundation for NIH is a nonprofit, 501(c) (3), corporation that actively seeks funding partners for a broad portfolio of groundbreaking programs and projects in support of biomedical research.
From the Website:
The mission of the Foundation for NIH is to foster public health through scientific discovery, translational research, and the dissemination of research results through specially-configured, high-impact public-private partnerships consistent with the priorities of the National Institutes of Health (NIH).
The foundation is not only involved in large, ambitious initiatives with potentially high impact on the lives of millions of the world’s citizens, but it also supports smaller focused programs in clinical training and ancillary support programs.
The foundation helps to underwrite biomedical initiatives that might not be attractive for private funding alone, or for one reason or another are not appropriate for wholly public funding. The foundation may take on projects that are particularly risky in terms of the likelihood of success or where companies may be willing to forgo profits because of early stage nature of the program or in the case of some global health initiatives due to the charitable nature of the project.
The foundation's projects tend to be longer-term, operating on a time scale that can be unattractive for private investors. At the same time the foundation is capable of responding quickly and nimbly to funding needs that are immediate and pressing.
With the goals of NIH as its guide, the foundation serves both the public and private sectors, helping them achieve significant breakthroughs in human health in areas of interest that overlap with those of NIH.
Related Reading:
Department of Defense Launches Personal Health Record Pilot – MiCare to Integrate with Google Health and HealthVault
Aetna and Microsoft join forces – Members will now be able to transfer health records to Microsoft Health Vault
0 comments :
Post a Comment